Sustained molecular response with imatinib in a leukemic form of idiopathic hypereosinophilic syndrome in relapse after allograft

Leukemia. 2004 Feb;18(2):354-5. doi: 10.1038/sj.leu.2403229.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Cord Blood Stem Cell Transplantation
  • Humans
  • Hypereosinophilic Syndrome / drug therapy*
  • Hypereosinophilic Syndrome / genetics
  • Hypereosinophilic Syndrome / therapy
  • Imatinib Mesylate
  • Leukemia / drug therapy*
  • Leukemia / genetics
  • Leukemia / therapy
  • Male
  • Molecular Diagnostic Techniques
  • Piperazines / therapeutic use*
  • Polymerase Chain Reaction
  • Pyrimidines / therapeutic use*
  • Recurrence
  • Remission Induction / methods
  • Transplantation, Homologous

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate